Investor Relations

Company Profile

Amphastar is a bio-pharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically-challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the Company sells insulin API products. Most of the Company’s finished products are used in hospital or urgent care clinical settings and are primarily contracted and distributed through group purchasing organizations and drug wholesalers.

Company News

27Feb 2025

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2024

More
20Feb 2025

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 27, 2025

More

Financial Calendar

27Feb 2025

Amphastar Fourth Quarter Earnings Call

Add to Calendar
13Jan 2025

Amphastar Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Add to Calendar

Email Alert

Subscribe to our newsletter

Spam protection: Please accept and solve the Captcha if prompted.
Youtube